SCHEMBL5828628

SCHEMBL5828628

CN1C(=O)C(c2c[nH]c3ncccc23)=C(c2cn(C(=O)OC(C)(C)C)c3ccccc23)C1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 4/20 0.48
MARK3 P27448 1/20 0.44
MAP4K2 Q12851 1/20 0.44
CAMK2B Q13554 1/20 0.44
PIM3 Q86V86 1/20 0.44
PIM2 Q9P1W9 1/20 0.44
PDPK1 O15530 1/20 0.44
TGFBR1 P36897 1/20 0.44
IKBKE Q14164 1/20 0.44
TBK1 Q9UHD2 1/20 0.44
BRD4 O60885 1/20 0.42
CREBBP Q92793 1/20 0.42
CAMK2D Q13557 2/20 0.42
RPS6KB1 P23443 1/20 0.41
SIRT2 Q8IXJ6 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
CCNT1 O60563 2/20 0.40
CDK9 P50750 2/20 0.40
CAMKK2 Q96RR4 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6575546 0.86 PIM1 (0.53) PIM1PDPK1TGFBR1IKBKETBK1
SCHEMBL5828402 0.86 PIM1 (0.48) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL7831573 0.85 SIRT2 (0.59) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL6081382 0.80 CREBBP (0.45) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL5828665 0.78 PIM1 (0.48) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL7822743 0.77 CAMK2D (0.44) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL28671383 0.74 SIRT2 (0.56) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL6081231 0.73 PRKCB (0.40) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL7826797 0.73 PRKCA (0.52) PIM1CAMK2DRPS6KB1SIRT2SIRT1
SCHEMBL28101324 0.73 CAMK2D (0.48) PIM1MARK3MAP4K2CAMK2BPIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7001906-B2 Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives LES LABORATOIRES SERVIER (FR) 2006-02-21 US disclosed
US-20040152721-A1 Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives LES LABORATOIRES SERVIER (FR) 2004-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152721-A1 Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives PYM1, PNPO, IDO1 PIM1 1680/4885MARK3 2224/4885MAP4K2 2818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.